Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Index by author

November 1, 2019; Volume 60,Issue 11
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Naka, Sadahiro

    1. Open Access
      Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice
      Fumihiko Soeda, Tadashi Watabe, Sadahiro Naka, Yuwei Liu, Genki Horitsugi, Oliver C. Neels, Klaus Kopka, Mitsuaki Tatsumi, Eku Shimosegawa, Frederik L. Giesel and Jun Hatazawa
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1594-1599; DOI: https://doi.org/10.2967/jnumed.118.223479
  2. Neels, Oliver C.

    1. Open Access
      Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice
      Fumihiko Soeda, Tadashi Watabe, Sadahiro Naka, Yuwei Liu, Genki Horitsugi, Oliver C. Neels, Klaus Kopka, Mitsuaki Tatsumi, Eku Shimosegawa, Frederik L. Giesel and Jun Hatazawa
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1594-1599; DOI: https://doi.org/10.2967/jnumed.118.223479
  3. Nessler, Ian

    1. You have access
      Blocking of Glucagonlike Peptide-1 Receptors in the Exocrine Pancreas Improves Specificity for β-Cells in a Mouse Model of Type 1 Diabetes
      Eshita Khera, Liang Zhang, Sheryl Roberts, Ian Nessler, Darleen Sandoval, Thomas Reiner and Greg M. Thurber
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1635-1641; DOI: https://doi.org/10.2967/jnumed.118.224881
  4. Nieh, Peter T.

    1. You have access
      18F-Fluciclovine Parameters on Targeted Prostate Biopsy Associated with True Positivity in Recurrent Prostate Cancer
      Olayinka A. Abiodun-Ojo, Akinyemi A. Akintayo, Oladunni O. Akin-Akintayo, Funmilayo I. Tade, Peter T. Nieh, Viraj A. Master, Mehrdad Alemozaffar, Adeboye O. Osunkoya, Mark M. Goodman, Baowei Fei and David M. Schuster
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1531-1536; DOI: https://doi.org/10.2967/jnumed.119.227033
  5. Niepsch, Karin

    1. You have access
      177Lu-PSMA-617 Radioligand Therapy in Metastatic Castration-Resistant Prostate Cancer Patients with a Single Functioning Kidney
      Jingjing Zhang, Harshad R. Kulkarni, Aviral Singh, Christiane Schuchardt, Karin Niepsch, Thomas Langbein and Richard P. Baum
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1579-1586; DOI: https://doi.org/10.2967/jnumed.118.223149
  6. Noordman, Bo Jan

    1. You have access
      Accuracy of 18F-FDG PET/CT in Predicting Residual Disease After Neoadjuvant Chemoradiotherapy for Esophageal Cancer
      Maria J. Valkema, Bo Jan Noordman, Bas P.L. Wijnhoven, Manon C.W. Spaander, Katharina Biermann, Sjoerd M. Lagarde, Roel J. Bennink, Wendy M.J. Schreurs, Mark J. Roef, Monique G.G. Hobbelink, Marcel J.R. Janssen, Laura H. Graven, J. Jan B. van Lanschot and Roelf Valkema
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1553-1559; DOI: https://doi.org/10.2967/jnumed.118.224196
  7. Nuyts, Johan

    1. You have access
      A Quantitative Evaluation of Joint Activity and Attenuation Reconstruction in TOF PET/MR Brain Imaging
      Ahmadreza Rezaei, Georg Schramm, Stefanie M.A. Willekens, Gaspar Delso, Koen Van Laere and Johan Nuyts
      Journal of Nuclear Medicine November 1, 2019, 60 (11) 1649-1655; DOI: https://doi.org/10.2967/jnumed.118.220871
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 60 (11)
Journal of Nuclear Medicine
Vol. 60, Issue 11
November 1, 2019
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Imaging Patients with Metastatic Castration-Resistant Prostate Cancer Using 89Zr-DFO-MSTP2109A Anti-STEAP1 Antibody
  • Impact of 18F-PSMA-1007 Uptake in Prostate Cancer Using Different Peptide Concentrations: Preclinical PET/CT Study on Mice
  • Is the Vision of Radioligand Therapy for Prostate Cancer Becoming a Reality? An Overview of the Phase III VISION Trial and Its Importance for the Future of Theranostics
  • Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Questioning Standard Clinical Practice Requires Indisputable Scientific Data
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire